Tag: industry trends

High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins

Posted on By digi

High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins Understanding Patient Enrollment in Clinical Trials: The Foundation for Effective Technology Adoption Patient enrollment in clinical trials serves as a critical element of the drug development process,…

Read More “High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins” »

Technology Adoption Curves (AI, DCT, eSource)

Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations

Posted on By digi

Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations The clinical research landscape is rapidly evolving. As professionals in clinical operations, regulatory affairs, and medical affairs comprehend the significance of adopting emerging technologies in clinical trials, understanding technology adoption curves becomes crucial. This article explores how AI, decentralized trials (DCT),…

Read More “Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations” »

Technology Adoption Curves (AI, DCT, eSource)

KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation

Posted on By digi

KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation The clinical research landscape is continuously evolving, particularly in the context of oncology clinical research. As trial methodologies adapt to various external pressures, biopharma companies are increasingly adopting advanced analytics tools to enhance their operational…

Read More “KPIs, Dashboards and Scorecards to Track Outsourcing Trends & Consolidation” »

Outsourcing Trends & Consolidation

Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation

Posted on By digi

Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation Introduction to Clinical Trial Outsourcing Trends In contemporary clinical research, outsourcing has become a pervasive practice among pharmaceutical and biopharmaceutical companies. The dynamics of clinical trials are evolving, necessitating a comprehensive…

Read More “Vendor, Site and Partner Negotiation Tactics Driven by Outsourcing Trends & Consolidation” »

Outsourcing Trends & Consolidation

Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks

Posted on By digi

Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks Introduction to Outsourcing Trends in Clinical Trials In recent years, the outsourcing landscape of clinical trials has undergone significant changes that reflect the evolving demands of the biopharmaceutical industry. As companies increasingly seek to enhance…

Read More “Scenario Planning: Best-Case and Worst-Case Outsourcing Trends & Consolidation Outlooks” »

Outsourcing Trends & Consolidation

Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered

Posted on By digi

Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered The landscape of clinical trials is continuously evolving, and with it comes a host of questions from investors, board members, and C-suite executives regarding outsourcing trends and consolidation in the industry. This comprehensive guide provides…

Read More “Investor, Board and C-Suite Questions Around Outsourcing Trends & Consolidation—Answered” »

Outsourcing Trends & Consolidation

Future Trends: AI, RWE and New Business Models in Outsourcing Trends & Consolidation

Posted on By digi

Future Trends: AI, RWE and New Business Models in Outsourcing Trends & Consolidation Future Trends: AI, RWE and New Business Models in Outsourcing Trends & Consolidation The landscape of clinical research is evolving with the integration of Artificial Intelligence (AI), Real-World Evidence (RWE), and innovative business models in outsourcing and consolidation. This step-by-step tutorial provides…

Read More “Future Trends: AI, RWE and New Business Models in Outsourcing Trends & Consolidation” »

Outsourcing Trends & Consolidation

Digital Tools and Analytics to Forecast and Monitor Outsourcing Trends & Consolidation

Posted on By digi

Digital Tools and Analytics to Forecast and Monitor Outsourcing Trends & Consolidation Digital Tools and Analytics to Forecast and Monitor Outsourcing Trends & Consolidation Introduction to Outsourcing Trends in Clinical Trials The landscape of clinical trials has undergone significant changes over the past several years, with outsourcing becoming a standard practice among biopharmaceutical companies. As…

Read More “Digital Tools and Analytics to Forecast and Monitor Outsourcing Trends & Consolidation” »

Outsourcing Trends & Consolidation

Risk Scenarios and Sensitivity Analyses for Outsourcing Trends & Consolidation

Posted on By digi

Risk Scenarios and Sensitivity Analyses for Outsourcing Trends & Consolidation Risk Scenarios and Sensitivity Analyses for Outsourcing Trends & Consolidation Introduction to Outsourcing in Clinical Trials Outsourcing in clinical trials has become a prevalent practice in the biopharmaceutical industry. As organizations strive to improve efficiency, optimize resources, and enhance their research capabilities, outsourcing certain functions…

Read More “Risk Scenarios and Sensitivity Analyses for Outsourcing Trends & Consolidation” »

Outsourcing Trends & Consolidation

Regulatory and Policy Shifts Reshaping Outsourcing Trends & Consolidation in the US, EU and UK

Posted on By digi

Regulatory and Policy Shifts Reshaping Outsourcing Trends & Consolidation in the US, EU and UK The landscape of clinical trials is continually evolving, influenced profoundly by regulatory and policy shifts. For clinical operations, regulatory affairs, and medical affairs professionals, understanding these changes is essential for navigating the complexities of clinical trial management. This guide provides…

Read More “Regulatory and Policy Shifts Reshaping Outsourcing Trends & Consolidation in the US, EU and UK” »

Outsourcing Trends & Consolidation